| 000 | 01781 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514223824.0 | ||
| 264 | 0 | _c20050802 | |
| 008 | 200508s 0 0 eng d | ||
| 022 | _a0944-1174 | ||
| 024 | 7 |
_a10.1007/s00535-004-1534-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMikami, Ken-ichiro | |
| 245 | 0 | 0 |
_aGabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats. _h[electronic resource] |
| 260 |
_bJournal of gastroenterology _cMar 2005 |
||
| 300 |
_a260-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarbon Tetrachloride _xadministration & dosage |
| 650 | 0 | 4 | _aChemical and Drug Induced Liver Injury |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aGabexate _xtherapeutic use |
| 650 | 0 | 4 |
_aInterleukin-1 _xblood |
| 650 | 0 | 4 | _aLethal Dose 50 |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 |
_aLiver Diseases _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSerine Proteinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aTransaminases _xblood |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aGoto, Takashi | |
| 700 | 1 | _aMiura, Kouichi | |
| 700 | 1 | _aOhshima, Shigetoshi | |
| 700 | 1 | _aYoneyama, Kazuo | |
| 700 | 1 | _aLin, Jiun-Guey | |
| 700 | 1 | _aWatanabe, Daisuke | |
| 700 | 1 | _aSegawa, Daisuke | |
| 700 | 1 | _aKataoka, Ei | |
| 700 | 1 | _aShibuya, Tomomi | |
| 700 | 1 | _aWatanabe, Sumio | |
| 773 | 0 |
_tJournal of gastroenterology _gvol. 40 _gno. 3 _gp. 260-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00535-004-1534-3 _zAvailable from publisher's website |
| 999 |
_c15498846 _d15498846 |
||